Hypoxia promotes BCMA loss and a suppressive secretome thereby hindering CAR T cell therapy in multiple myeloma
Abstract Introduction Multiple myeloma (MM) develops in the hypoxic bone marrow (BM) microenvironment, which alters tumor behavior and immune responses. While hypoxia is known to directly suppress immune function, its effect on immunotherapy-relevant antigen expression and the MM secretome remains u...
Guardat en:
| Autors principals: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2026-01-01
|
| Col·lecció: | Experimental Hematology & Oncology |
| Accés en línia: | https://doi.org/10.1186/s40164-025-00732-6 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|